Share-Based Compensation | Note 12. Share-Based Compensation On July 3, 2019, the Company’s Board of Directors adopted, and the Company’s sole stockholder approved, the 2019 Equity Incentive Plan (the “2019 Equity Incentive Plan”), which became effective on July 17, 2019, the date of effectiveness of the Company’s IPO (as defined below) registration statement on Form S-1. As of June 30, 2021, 2,312,609 shares were available for issuance under the 2019 Equity Incentive Plan. Restricted Stock Awards Prior to the liquidation and dissolution of AssetMark Holdings, our former parent company, and the IPO, all officers and certain sales employees of AssetMark Holdings held Class C Common Units of AssetMark Holdings, which were intended to be treated as profits interests. Immediately following the pricing of the IPO, AssetMark Holdings liquidated and dissolved and distributed shares of the Company’s common stock to its members, including an aggregate number of restricted stock awards (“RSAs”) equal to 6,309,049 shares of the Company’s common stock to the holders of the Class C Common Units of AssetMark Holdings. These RSAs are subject to the same vesting schedule as the Class C Common Units of AssetMark Holdings, with 50% of the RSAs scheduled to vest in three (3) equal installments on the third, fourth and fifth anniversaries of November 18, 2016, subject to the recipient’s continued employment through the vesting date, and 50% subject to the recipient’s continued employment through February 1, 2021 and the satisfaction of a performance-based vesting condition. The performance condition for these RSAs was deemed to have been satisfied in connection with the IPO. In the event that the vesting conditions are not satisfied for any portion of an award, the shares covered by such RSAs will transfer automatically to the Company. 402,640 and 3,551,213 RSAs vested during the three and six months ended June 30, 2021, respectively. Share-based compensation expense related to the RSAs was $4,396 and $12,782 for the three months ended June 30, 2021 and 2020, respectively, and $34,970 and $25,034 for the six months ended June 30, 2021 and 2020, respectively. Stock Options In connection with the IPO, the Company issued options to certain officers to acquire an aggregate of 918,981 shares of the Company’s common stock outside of the 2019 Equity Incentive Plan, with an exercise price of $22 dollars per share. Each of these options is scheduled to vest and become exercisable in substantially equal installments on each of the first three anniversaries of July 18, 2019, subject to the recipient’s continued employment through the vesting date and have a ten-year Share-based compensation expense related to the stock options was $397 and $583 for the three months ended June 30, 2021 and 2020, respectively, and $1,630 and $1,167 for the six months ended June 30, 2021 and 2020, respectively. Restricted Stock Units Also in connection with the IPO, the Company issued restricted stock units (“RSUs”) to certain officers and sales employees covering an aggregate of 85,737 shares of the Company’s common stock under the 2019 Equity Incentive Plan. Each of these RSUs is scheduled to vest in substantially equal installments on each of the first three anniversaries of July 18, 2019. During 2020, the Company issued 310,225 RSUs to all officers, certain employees and independent directors of the board. During 2021, the Company issued 451,344 RSUs to all officers, certain employees and independent directors of the board. Most of these RSUs are scheduled to vest in substantially equal installments on each of the first four anniversaries of the date of grant. Share-based compensation expense related to the RSUs was $1,232 and $431 for the three months ended June 30, 2021 and 2020, respectively, and $2,103 and $783 for the six months ended June 30, 2021 and 2020, respectively. Stock Appreciation Rights During 2020, the Company issued stock appreciation rights (“SARs”) with an aggregate grant date fair value of $9,239 to certain officers with respect to 831,902 shares of the Company’s common stock under the 2019 Equity Incentive Plan. Each SAR has a strike price equal to the fair market value of the Company’s common stock on the date of grant and is scheduled to vest and become exercisable in substantially equal installments on each of the first four anniversaries of the date of grant. Upon exercise, each of these SARs will be settled in shares of the Company’s common stock with a value equal to the excess, if any, of the fair market value of the Company’s common stock measured on the exercise date over the strike price. During 2021, the Company issued 894,411 SARs to certain officers. Share-based compensation expense related to SARs was $651 and $138 for the three months ended June 30, 2021 and 2020, respectively, and $1,401 and $138 for the six months ended June 30, 2021 and 2020, respectively . |